Home | Site Map
 
 
[.:Partners:.]

[.:Contenuti:.]
BRISTOL MYERS SQUIBB

Bristol-Myers Squibb And The National AIDS Fund Announce World AIDS Day Campaign To Shine A Light On The HIV/AIDS Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) in cooperation with the National AIDS Fund today launched the third annual "Light to Unite" campaign in support of World AIDS Day. This year's "Light to Unite" program shines a light on the devastating impact of the HIV/AIDS epidemic in underserved communities throughout the United States. [click link for full article]
Bristol-Myers Squibb Company Announces Voluntary Delisting From NYSE Arca PR Newswire via Yahoo! Finance
Bristol-Myers Squibb Company today announced that it will voluntarily withdraw its securities from listing on NYSE Arca, Inc., formerly the Pacific Exchange.
Bristol-Myers Withdraws From NYSE Arca AP via Yahoo! Finance
Bristol-Myers Squibb Co., one of the nation's biggest drug makers, said Friday it is voluntarily withdrawing its stock listing from NYSE Arca Inc., formerly the Pacific Exchange.
Bristol-Myers Squibb Co. property for sale Princeton Packet
A 135-acre vacant parcel of land at the corner of Princeton Pike and Lewisville Road is for sale.
Bristol-Myers and National AIDS campaigns on AIDS PharmaBiz
Bristol-Myers Squibb Company in cooperation with the National AIDS Fund launched the third annual "Light to Unite" campaign in support of World AIDS Day. This year's "Light to Unite" programme shines a light on the devastating impact of the HIV/AIDS epidemic in underserved communities throughout the United States.
No ailing grades in this class The Star-Ledger
It's time for morning lessons, so "Miss Flo" gently nudges 6-year-old Malcolm King away from his computer game. "Before we do aliens, we have to do school," says Florence Carrano, a certified teacher on staff at the Bristol-Myers Squibb Children's Hospital in New Brunswick.
'Light to Unite' campaign launched to raise funds for HIV/AIDS The Advocate
In support of World AIDS Day, Bristol-Myers Squibb in collaboration with the National AIDS Fund launched the third annual “Light to Unite” campaign earlier this week.
"One Vision 2007" Competition Launches Today Presseportal
Paris (ots/PRNewswire) - - Photographers From Across Europe Invited to Participate in Contest to Fight Stigma and Discrimination of HIV/AIDS Patients. Bristol-Myers Squibb announced today - World AIDS Day - the launch of the fourth
Bristol-Myers Squibb and The National AIDS Fund Announce World AIDS Day Campaign to Shine a Light on the HIV/AIDS Finanzen.net
DOW J. : 12141 (-1,13%)
Pliva receives US FDA approval for pravastatin tablets PharmaBiz
The Croatia-based Pliva, the subsidiary of the New Jersey-based Barr Pharmaceuticals Inc, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market pravastatin tablets 10 mg, 20 mg, and 40 mg, the generic version of Bristol-Myers Squibb's Pravachol (pravastatin sodium) tablets.

Official Site Bristol-Myers Squibb Italia - Note Legali
Bristol-Myers Squibb si adopererà in modo da racchiudere in questo sito Bristol-Myers Squibb non sarà responsabile per eventuali danni derivanti
BMSA Internet
Mini Homepage Image, Mini About Us Image, Mini Research & Development Image, Mini Our Medicines Image, Mini Working for BMSA Image
Bristol-Myers Squibb - Clinical Trials Disclosure
Welcome to Bristol-Myers Squibb’s Clinical Trials Disclosure website. Bristol-Myers Squibb is committed to providing parency into clinical trial
Bristol-Myers Squibb GmbH & Co. KGaA
Die Medikamente von Bristol-Myers Squibb werden seit vielen Jahren eingesetzt, um verschiedene Krebserkrankungen zu behandeln. Ihre Anwendungsgebiete werden
Bristol-Myers Squibb Belgium
Visit Bristol-Myers Squibb Company on the World Wide Web. Bristol-Myers Squibb Belgium will be happy to provide you information*. Please mail us :
Bristol-Myers Squibb Medical Imaging
Cardiolite® and Definity® are registered trademarks of Bristol-Myers Squibb Medical Imaging, Inc. Any unlicensed use of these trademarks is expressly
BMY: Summary for BRISTOL MYERS SQIBB - Yahoo! Finance
Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceutical and other
Ostomy Supplier - Wound Management - Ostomy and Wound Care Management
Manufacturer of ostomy care and modern wound care products and a leading maker of skin care and continence care products; based in Skillman, New Jersey.
BMS Canada - Home
Bristol-Myers Squibb Canada is a pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb - Zimmer Spin-Off Info
Q1: I own Bristol-Myers Squibb shares. What do I get as a result of the Zimmer If you were a stockholder of record of Bristol-Myers Squibb common stock, bristol+myers+squibb: | | | | bristol+myers+squibb
Cerca con Google


 
 
©2006 home |azienda | flotta | privacy | Contatti | bristol+myers+squibb Tutti i diritti sono riservati.